Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a Targeted Approach for Immunotherapy ResearchThe Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay is a ready to use kit consisting of 20 biologically relevant cytokines in immunotherapy as a tool to aid researchers in studying immune responses or adverse reactions.Credit: Bio-Rad LaboratoriesHercules, CA — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for immunotherapy research.

Messenger molecules such as cytokines are involved in the communication within the immune system and play a vital role in a variety of conditions including cancer and autoimmune diseases. Advancing discoveries in immunotherapy can be time consuming as existing immunoassay tools may not be tailored to cover specific targets including cytokine targets. The Bio-Plex Pro Human Immunotherapy Panel 20-plex covers biologically-researched cytokine targets that are associated with immunotherapy research.

About the Bio-Plex Pro Human Immunotherapy Panel 20-plex

The Bio-Plex Pro Human Immunotherapy Panel 20-plex is a ready-to-use, 1 x 96-well kit that contains premixed magnetic capture beads and detection antibodies, standards, and buffers that produce results for 20 different cytokines using only 12.5uL of sample. The Bio-Plex Panel maximizes laboratory efficiency by generating key actionable data in a single experiment. The kit is compatible with other Bio-Rad platforms including the Bio-Plex 200, Bio-Plex 3D Systems, as well as all other xMAP platforms.

For more information about the Bio-Plex Pro Human Immunotherapy Panel 20-plex and other Bio-Plex instruments, assays, and software, please visit bio-rad.com/bio-pleximmunotherapykit

Bio-Plex and Bio-Rad are trademarks of Bio-Rad Laboratories, Inc. in certain jurisdictions.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 8,000 employees worldwide. Bio-Rad had revenues exceeding $2.2 billion in 2018. For more information, please visit www.bio-rad.com.